CO2024003018A2 - Derivados de nucleósido y profármacos de los mismos que tienen acción inhibidora del crecimiento viral - Google Patents
Derivados de nucleósido y profármacos de los mismos que tienen acción inhibidora del crecimiento viralInfo
- Publication number
- CO2024003018A2 CO2024003018A2 CONC2024/0003018A CO2024003018A CO2024003018A2 CO 2024003018 A2 CO2024003018 A2 CO 2024003018A2 CO 2024003018 A CO2024003018 A CO 2024003018A CO 2024003018 A2 CO2024003018 A2 CO 2024003018A2
- Authority
- CO
- Colombia
- Prior art keywords
- prodrugs
- inhibitory action
- growth inhibitory
- viral growth
- nucleoside derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021134801 | 2021-08-20 | ||
| PCT/JP2022/031308 WO2023022216A1 (ja) | 2021-08-20 | 2022-08-19 | ウイルス増殖抑制作用を有するヌクレオシド誘導体及びそれらのプロドラッグ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024003018A2 true CO2024003018A2 (es) | 2024-03-18 |
Family
ID=85240607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0003018A CO2024003018A2 (es) | 2021-08-20 | 2024-03-13 | Derivados de nucleósido y profármacos de los mismos que tienen acción inhibidora del crecimiento viral |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250170155A1 (https=) |
| EP (1) | EP4389750A4 (https=) |
| JP (1) | JPWO2023022216A1 (https=) |
| KR (1) | KR20240050362A (https=) |
| CN (1) | CN118119624A (https=) |
| AU (1) | AU2022331233A1 (https=) |
| CA (1) | CA3229752A1 (https=) |
| CO (1) | CO2024003018A2 (https=) |
| IL (1) | IL310854A (https=) |
| MX (1) | MX2024002116A (https=) |
| PE (1) | PE20240654A1 (https=) |
| WO (1) | WO2023022216A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300412A (en) | 2020-08-24 | 2023-04-01 | Gilead Sciences Inc | Phospholipid compounds and their uses |
| IL300453A (en) | 2020-08-27 | 2023-04-01 | Gilead Sciences Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS |
| TW202344257A (zh) | 2020-10-16 | 2023-11-16 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| KR20240154647A (ko) | 2022-03-02 | 2024-10-25 | 길리애드 사이언시즈, 인코포레이티드 | 바이러스성 감염 치료를 위한 화합물 및 방법 |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3277623D1 (en) | 1981-07-31 | 1987-12-17 | Sloan Kettering Inst Cancer | Anti-leukemic beta-glycosyl c-nucleosides |
| US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| US7109331B2 (en) | 2000-08-29 | 2006-09-19 | Industrial Research Limited | 5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors |
| US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| US20040063658A1 (en) | 2002-05-06 | 2004-04-01 | Roberts Christopher Don | Nucleoside derivatives for treating hepatitis C virus infection |
| EA014685B1 (ru) | 2003-04-25 | 2010-12-30 | Джилид Сайэнс, Инк. | Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе |
| CA2568379A1 (en) | 2004-06-15 | 2005-12-29 | Merck & Co., Inc. | C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| US7560434B2 (en) | 2004-06-22 | 2009-07-14 | Biocryst Pharmaceuticals, Inc. | AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| AU2005302448B2 (en) | 2004-10-29 | 2012-07-19 | Biocryst Pharmaceuticals, Inc. | Therapeutic furopyrimidines and thienopyrimidines |
| WO2007069924A1 (en) | 2005-12-15 | 2007-06-21 | Industrial Research Limited | Deazapurine analogs of 4'-aza-l-nucleosides |
| MX2009007333A (es) * | 2007-01-12 | 2009-08-31 | Biocryst Pharm Inc | Analogos de nucleosidos antivirales. |
| HRP20120914T1 (hr) | 2007-05-10 | 2012-12-31 | Biocryst Pharmaceuticals, Inc. | Spojevi tetrahidrofuro[3,4-d]dioksolana, namijenjeni upotrebi u lijeäśenju virusnih infekcija i raka |
| WO2010002877A2 (en) | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| TW201305185A (zh) | 2010-09-13 | 2013-02-01 | 吉李德科學股份有限公司 | 用於抗病毒治療之２’－氟取代之碳－核苷類似物 |
| US9290501B2 (en) | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
| MD4496C1 (ro) * | 2012-03-13 | 2018-02-28 | Gilead Sciences, Inc. | Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral |
| AR090699A1 (es) | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| WO2014035140A2 (en) | 2012-08-30 | 2014-03-06 | Kainos Medicine, Inc. | Compounds and compositions for modulating histone methyltransferase activity |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 抗ウイルス性アザ糖を含有するヌクレオシド |
| CA2911424C (en) | 2013-05-14 | 2021-11-30 | Biocryst Pharmaceuticals, Inc. | Anti-influenza imino-ribose pyrrolopyrimidine derivatives |
| UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| WO2015143712A1 (en) | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
| TWI687432B (zh) | 2014-10-29 | 2020-03-11 | 美商基利科學股份有限公司 | 絲狀病毒科病毒感染之治療 |
| CN107108683A (zh) | 2014-10-31 | 2017-08-29 | 共晶制药股份有限公司 | 用于治疗黄病毒科病毒和癌症的2’,2’‑二卤代核苷类似物 |
| CN110678473A (zh) | 2017-04-25 | 2020-01-10 | 大原药品工业株式会社 | 核苷类抗癌药或抗病毒药的5’位二苄基单磷酸酯衍生物 |
| WO2018230479A1 (ja) | 2017-06-13 | 2018-12-20 | 大原薬品工業株式会社 | ヌクレオシド系抗がん剤又は抗ウィルス剤の５'位シリルエーテル誘導体 |
| CA3075950A1 (en) * | 2017-09-18 | 2019-03-21 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| CA3126348A1 (en) | 2018-01-12 | 2020-07-18 | Board Of Regents Of The University Of Nebraska | Antiviral prodrugs and formulations thereof |
| WO2021040356A1 (en) | 2019-08-23 | 2021-03-04 | Kainos Medicine, Inc. | C-nucleosides, c-nucleotides and their analogs, equivalents and prodrugs thereof for ectonucleotidase inhibition |
| CN112778310B (zh) | 2020-04-20 | 2025-05-30 | 中国科学院上海药物研究所 | 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用 |
| CN112062800B (zh) | 2020-09-02 | 2022-11-18 | 广东东阳光药业有限公司 | 核苷化合物的氨基磷酸酯衍生物及其用途 |
| CN112010916B (zh) | 2020-09-09 | 2022-12-27 | 广东东阳光药业有限公司 | 核苷化合物的氨基磷酸酯衍生物及其用途 |
-
2022
- 2022-08-19 EP EP22858533.7A patent/EP4389750A4/en active Pending
- 2022-08-19 MX MX2024002116A patent/MX2024002116A/es unknown
- 2022-08-19 JP JP2023542451A patent/JPWO2023022216A1/ja active Pending
- 2022-08-19 AU AU2022331233A patent/AU2022331233A1/en active Pending
- 2022-08-19 CA CA3229752A patent/CA3229752A1/en active Pending
- 2022-08-19 PE PE2024000272A patent/PE20240654A1/es unknown
- 2022-08-19 IL IL310854A patent/IL310854A/en unknown
- 2022-08-19 KR KR1020247008024A patent/KR20240050362A/ko active Pending
- 2022-08-19 CN CN202280069993.0A patent/CN118119624A/zh active Pending
- 2022-08-19 US US18/684,486 patent/US20250170155A1/en active Pending
- 2022-08-19 WO PCT/JP2022/031308 patent/WO2023022216A1/ja not_active Ceased
-
2024
- 2024-03-13 CO CONC2024/0003018A patent/CO2024003018A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240050362A (ko) | 2024-04-18 |
| WO2023022216A1 (ja) | 2023-02-23 |
| MX2024002116A (es) | 2024-03-06 |
| EP4389750A4 (en) | 2025-10-01 |
| CA3229752A1 (en) | 2023-02-23 |
| EP4389750A1 (en) | 2024-06-26 |
| JPWO2023022216A1 (https=) | 2023-02-23 |
| AU2022331233A1 (en) | 2024-02-29 |
| IL310854A (en) | 2024-04-01 |
| US20250170155A1 (en) | 2025-05-29 |
| CN118119624A (zh) | 2024-05-31 |
| PE20240654A1 (es) | 2024-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2024003018A2 (es) | Derivados de nucleósido y profármacos de los mismos que tienen acción inhibidora del crecimiento viral | |
| CL2023003041A1 (es) | Derivados de triazina que tienen actividad inhibidora de la replicación del virus y composición farmacéutica | |
| GEP20247607B (en) | Nitrile-containing antiviral compounds | |
| AR130699A2 (es) | Inhibidores de la transcriptasa inversa de nucleósidos sustituidos en 4 | |
| UY37710A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| CL2020000487A1 (es) | Agentes antivirales contra la hepatitis b. | |
| CL2020000086A1 (es) | Derivado de anillo fusionado que tiene una actividad inhibidora de monoacilglicerol aciltransferasa 2 (mgat-2). | |
| MX2022010040A (es) | Compuestos moduladores de gcn2. | |
| UY37367A (es) | Nuevos compuestos para uso en el tratamiento de una infección viral y composiciones de los mismos | |
| CO2019005534A2 (es) | Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih | |
| AR119174A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| MX2020004838A (es) | Nuevas indol-2-carboxamidas sustituidas con pirazolopiperidina, de alta actividad, activas contra el virus de la hepatitis b (vhb). | |
| CL2020001875A1 (es) | Inhibidores de pi4kiiiß | |
| CR20120503A (es) | Inhibidores no nucleosídicos de la transcriptasa inversa | |
| ECSP109919A (es) | Compuesto de piridacina cristalina | |
| ECSP21079317A (es) | Nuevas indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb) | |
| MX2020009530A (es) | Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa. | |
| MX387359B (es) | Inhibidores de cinasa activada por mitógeno 2 (mk2), síntesis de los mismos, e intermediarios de los mismos. | |
| GEP20207190B (en) | Methods for treatment and prophylaxis of hiv and aids | |
| MX2022011333A (es) | Compuestos moduladores de gpr52. | |
| ECSP20056232A (es) | Régimen posológico del modulador del ensamblaje de la cápside | |
| CL2020003380A1 (es) | Compuestos que aumentan la actividad del proteosoma. | |
| MX2022004144A (es) | Compuestos heterobiciclicos de arilo como bloqueadores del canal de potasio tipo shaker kv1.3. | |
| BR112017015693A2 (pt) | ciclopropabenzofuranil piridopirazinadionas | |
| PE20221009A1 (es) | Sintesis de un inhibidor de calicreina plasmatica a escala de proceso |